when your predicted lung function is 64% of normal due to disease, and you get an absulute increase of over 10% you are getting some serious clinical benefit. its easy to see in a relative sense the benefit was >10% (10.5/64x100=16+%), and if you consider that a 35% absolute increase puts you at 100% predicted or equal to those with no disability whatsoever, you see that this drug essentially gets you a third of the way there another perspective on the clinical benefit - 80% predicted is usually considered the lower bound of normal - pts on drug got to 75% it wouldn't surprise me if these people end up living decades longer because of this drug
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.